- Ongoing, recruitingTherapeutic use (Phase IV)
PROgnostic value of precision medicine in patients with Myocardial Infarction and non-obStructive coronary artEries: the PROMISE study
The PROMISE study looks at improving care for people who've had a heart attack but don't have blocked arteries. It checks how different treatments affect their angina (chest pain) and quality of life over a year.
For: Myocardial infarction with non-obstructive coronary arteries (MINOCA)Italy - RecruitingNA
Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy
This study looks into 'broken heart syndrome' (Takotsubo cardiomyopathy) to understand why it happens and how different heart medicines affect it. Researchers use special MRI scans with a dye called manganese to see changes in the heart and how treatments might help.
For: Takotsubo CardiomyopathyUnited Kingdom - AuthorisedTherapeutic use (Phase IV)
NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease; a prospective randomized trial
This study looks at how certain blood pressure and heart medications might help people with type 2 diabetes, who haven't had heart problems before, to avoid future heart issues. It focuses on a specific blood marker (NT-proBNP) to guide treatment.
For: Diabetes mellitus Type 2Spain · Austria